Translationof foreigncurrencynet debt intoUS Dollars hadtheeffect ofincreasingnetdebt by$71minthe three-year periodended 31December2008.
Net Cash Inflow from Operating Activities Cash generated from operations in 2008 of $815m is after paying out $10m of macrotextured claim settlements unreimbursed by insurers, $48m of acquisition related costs and $28m of restructuring and rationalisation expenses.
In 2007 cash generated from operations of $693m was after paying out $23m of macrotextured claim settlements unreimbursed by insurers offset by a receipt of $22m from a successful settlement, $33m of acquisitionrelated costs, $ andalegal settlement of$30m.
In 2006 cash generated from operations of $506m was after paying $33m for macrotextured claim settlements unreimbursed by insurers, $4m of acquisition related costs and $21m of restructuring and rationalisation expenses.
Capital Expenditure The Groups   generated by business operations and, where necessary, through short-term committed and uncommitted bank facilities.
In recent years capital expenditure on tangible and intangible fixed assets has represented approximately 6-8%.
In 2008 capital expenditure of $292m $289m net of disposals of property, plant and equipment was incurred.
The principal areas of investment were the placement of orthopaedic instruments with customers, patents and licenses, plant .
At 31 December 2008, $27m of capital expenditure had been contracted but not provided for which will be .
44 Acquisitions and Disposals In the three-year period ended 31 December 2008, $880m was spent on acquisitions, funded from net debt and cash inflows.
This comprised Plus $769m, OBI $71m, BlueSky $16m, Acticoat $10m, Collagenase $5m, MMT $3m, Versajet $3m, and$.
Liquidity The Groups policy is to ensure that it has sufficient funding and facilities in place to meet foreseeable borrowing requirements.
In May 2007 the Group entered into a committed $2,500m revolving multicurrency loan facility.
This facility comprises a $1,000m 364 day facility, which was extended into a term loan for a further 4 years in , andafive year$.
At 31 December 2008, the Group held $145m in cash and balances at bank.
The Group has drawings under uncommitted facilities of $340m and has committed facilities of $2,512m.
Of the undrawn committed facilities of $1,182m, $10m expires in 2009 and $1,172m in 2012.
In addition Smith & Nephew has finance lease commitments of $31m of which $14m extends beyond five years.
Smith & Nephew intends to repay the  .
The principal variations in the Groups borrowing requirements result from the timing of dividend payments, acquisitions and disposals of businesses, the share buy-back programme announced as suspended in November 2008, timing of capital expenditure and working capital fluctuations.
In 2008 the settlement of macrotexturedpatient claimswas .
Smith & Nephew believes that its capital expenditure needs and its working capital funding for 2009, as well as its otherknownorexpected , canbe met fromits .
The Groups planned future contributions are considered adequate to cover the current under funded position in theGroupsdefined benefit plans.
Further disclosure regarding borrowings, related covenants and the liquidity risk exposures is set out in Note 21 of the Notes to the Group Accounts.
The Group believes that the borrowing facilities do not contain restrictions that areexpected   future.
Going Concern Although, as disclosed in the Risk factors section, the Group is not immune from the current world economic crisis, the Directors do believe that the Group is well placed to manage its business risks successfully despite the .
Payment Policies It is the Groups policy to ensure that suppliers are paid within agreed terms.
At the year-end, the Parent Companyhadnotrade creditors.
